Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: Four open-label, randomized crossover trials in healthy volunteers
- 30 November 2009
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 31 (11), 2722-2734
- https://doi.org/10.1016/j.clinthera.2009.11.025
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Evidence of the Dual Mechanisms of Action of VenlafaxineArchives of General Psychiatry, 2000
- Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropionJournal of Affective Disorders, 1998
- Absolute Bioavailability and Electroencephalographic Effects of Conventional and Extended‐Release Formulations of Venlafaxine in Healthy SubjectsThe Journal of Clinical Pharmacology, 1998
- Pharmacokinetics of once-daily venlafaxine extended release in healthy volunteersCurrent Therapeutic Research, 1997
- Venlafaxine: A Structurally Unique and Novel AntidepressantAnnals of Pharmacotherapy, 1995
- VenlafaxineDrugs, 1995